InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ACADIA PHARMACEUTICALS INC

ACAD Clue Score69
United States Fiscal year ends December CIK 0001070494 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
James Kihara
26 Jun 2026
Principal Accounting Officer
Sold on a plan
11,421
$26.08
$297.91K
Mark C. Schneyer
18 Aug 2025
EVP, Chief Financial Officer
Sold on a plan
22,000
$25.18
$554.02K
Mark C. Schneyer
16 May 2025
EVP, Chief Financial Officer
Sold on a plan
2,000
$25.00
$50.00K
James Kihara
16 May 2025
Principal Accounting Officer
Sold on a plan
2,000
$20.00
$40.00K
James Kihara
16 May 2025
Principal Accounting Officer
Sold on a plan
2,000
$25.00
$50.00K
James Kihara
15 Dec 2023
Principal Accounting Officer
Sold on a plan
2,000
$28.30
$56.60K
James Kihara
15 Sep 2023
Principal Accounting Officer
Sold on a plan
2,000
$25.88
$51.76K
Mark C. Schneyer
21 Aug 2023
EVP, Chief Financial Officer
Sold on a plan
10,000
$29.00
$289.97K
Stephen Davis
12 Jul 2023
CEO
Sold on a plan
55,104
$25.05
$1.38M
Stephen Davis
11 Jul 2023
CEO
Sold on a plan
16,498
$25.00
$412.45K
James Kihara
15 Jun 2023
Principal Accounting Officer
Sold on a plan
2,000
$24.15
$48.30K
Laura Brege
12 Jun 2023
Director
Sold on a plan
4,500
$24.87
$111.91K
Showing 250 of 275 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 324
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 89
Sales at will 107
Transactions with no price 0
Shares from compensation/vesting 6,108,828
Sales filed before the plan box existed 36
History held since 13 Dec 2006